STOCK TITAN

[144] ARTIVION, INC. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Artivion (AORT) received a Form 144 notice from a shareholder for a proposed sale of 10,000 common shares with an aggregate market value of $461,800. The filing lists an approximate sale date of 11/11/2025 on the NYSE through Fidelity Brokerage Services LLC.

The securities to be sold were acquired from the issuer via an option granted on 11/08/2022, with acquisition and cash payment dated 11/11/2025. Shares outstanding were 47,374,939.

The filer reported prior sales in the last three months: 23,356 shares on 08/12/2025 for $1,004,605.97 and 10,000 shares on 08/25/2025 for $443,700.00.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Artivion, Inc.

NYSE:AORT

AORT Rankings

AORT Latest News

AORT Latest SEC Filings

AORT Stock Data

1.82B
43.32M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
KENNESAW